TP53 and head and neck squamous cell carcinoma: In order to evaluate molecular alterations that are potentially associated with aggressiveness of head and neck squamous cell carcinomas, we studied the prognostic impact of the immunohistochemical expression of p53, c-erbB-2 and EGFR on excised head and neck squamous cell carcinomas and adjacent normal mucosa.